Prevalence of Symptoms of Bladder Pain Syndrome/Interstitial Cystitis Among Adult Females in the United States
Purpose Bladder pain syndrome/interstitial cystitis is a poorly understood condition that can cause serious disability. We provide the first population based symptom prevalence estimate to our knowledge among United States adult females. Materials and Methods We developed and validated 2 case defini...
Saved in:
| Published in | The Journal of urology Vol. 186; no. 2; pp. 540 - 544 |
|---|---|
| Main Authors | , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
New York, NY
Elsevier Inc
01.08.2011
Elsevier |
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Purpose Bladder pain syndrome/interstitial cystitis is a poorly understood condition that can cause serious disability. We provide the first population based symptom prevalence estimate to our knowledge among United States adult females. Materials and Methods We developed and validated 2 case definitions to identify bladder pain syndrome/interstitial cystitis symptoms. Beginning in August 2007 we telephoned United States households, seeking adult women with bladder symptoms or a bladder pain syndrome/interstitial cystitis diagnosis. Second stage screening identified those subjects who met case definition criteria. Each completed a 60-minute interview on the severity and impact of bladder symptoms, health care seeking and demographics. Data collection ended in April 2009. Using population and nonresponse weights we calculated prevalence estimates based on definitions spanning a range of sensitivity and specificity. We used United States Census counts to estimate the number of affected women in 2006. The random sample included 146,231 households, of which 131,691 included an adult female. Of these households 32,474 reported an adult female with bladder symptoms or diagnosis, of which 12,752 completed the questionnaire. Results Based on the high sensitivity definition 6.53% (95% CI 6.28, 6.79) of women met symptom criteria. Based on the high specificity definition 2.70% (95% CI 2.53, 2.86) of women met the criteria. These percentages translated into 3.3 to 7.9 million United States women 18 years old or older with bladder pain syndrome/interstitial cystitis symptoms. Symptom severity and impact were comparable to those of adult women with established diagnoses. However, only 9.7% of the women reported being assigned a bladder pain syndrome/interstitial cystitis diagnosis. Conclusions Bladder pain syndrome/interstitial cystitis symptoms are widespread among United States women and associated with considerable disability. These results suggest bladder pain syndrome/interstitial cystitis may be underdiagnosed. |
|---|---|
| AbstractList | Bladder pain syndrome/interstitial cystitis is a poorly understood condition that can cause serious disability. We provide the first population based symptom prevalence estimate to our knowledge among United States adult females.
We developed and validated 2 case definitions to identify bladder pain syndrome/interstitial cystitis symptoms. Beginning in August 2007 we telephoned United States households, seeking adult women with bladder symptoms or a bladder pain syndrome/interstitial cystitis diagnosis. Second stage screening identified those subjects who met case definition criteria. Each completed a 60-minute interview on the severity and impact of bladder symptoms, health care seeking and demographics. Data collection ended in April 2009. Using population and nonresponse weights we calculated prevalence estimates based on definitions spanning a range of sensitivity and specificity. We used United States Census counts to estimate the number of affected women in 2006. The random sample included 146,231 households, of which 131,691 included an adult female. Of these households 32,474 reported an adult female with bladder symptoms or diagnosis, of which 12,752 completed the questionnaire.
Based on the high sensitivity definition 6.53% (95% CI 6.28, 6.79) of women met symptom criteria. Based on the high specificity definition 2.70% (95% CI 2.53, 2.86) of women met the criteria. These percentages translated into 3.3 to 7.9 million United States women 18 years old or older with bladder pain syndrome/interstitial cystitis symptoms. Symptom severity and impact were comparable to those of adult women with established diagnoses. However, only 9.7% of the women reported being assigned a bladder pain syndrome/interstitial cystitis diagnosis.
Bladder pain syndrome/interstitial cystitis symptoms are widespread among United States women and associated with considerable disability. These results suggest bladder pain syndrome/interstitial cystitis may be underdiagnosed. Bladder pain syndrome/interstitial cystitis is a poorly understood condition that can cause serious disability. We provide the first population based symptom prevalence estimate to our knowledge among United States adult females.PURPOSEBladder pain syndrome/interstitial cystitis is a poorly understood condition that can cause serious disability. We provide the first population based symptom prevalence estimate to our knowledge among United States adult females.We developed and validated 2 case definitions to identify bladder pain syndrome/interstitial cystitis symptoms. Beginning in August 2007 we telephoned United States households, seeking adult women with bladder symptoms or a bladder pain syndrome/interstitial cystitis diagnosis. Second stage screening identified those subjects who met case definition criteria. Each completed a 60-minute interview on the severity and impact of bladder symptoms, health care seeking and demographics. Data collection ended in April 2009. Using population and nonresponse weights we calculated prevalence estimates based on definitions spanning a range of sensitivity and specificity. We used United States Census counts to estimate the number of affected women in 2006. The random sample included 146,231 households, of which 131,691 included an adult female. Of these households 32,474 reported an adult female with bladder symptoms or diagnosis, of which 12,752 completed the questionnaire.MATERIALS AND METHODSWe developed and validated 2 case definitions to identify bladder pain syndrome/interstitial cystitis symptoms. Beginning in August 2007 we telephoned United States households, seeking adult women with bladder symptoms or a bladder pain syndrome/interstitial cystitis diagnosis. Second stage screening identified those subjects who met case definition criteria. Each completed a 60-minute interview on the severity and impact of bladder symptoms, health care seeking and demographics. Data collection ended in April 2009. Using population and nonresponse weights we calculated prevalence estimates based on definitions spanning a range of sensitivity and specificity. We used United States Census counts to estimate the number of affected women in 2006. The random sample included 146,231 households, of which 131,691 included an adult female. Of these households 32,474 reported an adult female with bladder symptoms or diagnosis, of which 12,752 completed the questionnaire.Based on the high sensitivity definition 6.53% (95% CI 6.28, 6.79) of women met symptom criteria. Based on the high specificity definition 2.70% (95% CI 2.53, 2.86) of women met the criteria. These percentages translated into 3.3 to 7.9 million United States women 18 years old or older with bladder pain syndrome/interstitial cystitis symptoms. Symptom severity and impact were comparable to those of adult women with established diagnoses. However, only 9.7% of the women reported being assigned a bladder pain syndrome/interstitial cystitis diagnosis.RESULTSBased on the high sensitivity definition 6.53% (95% CI 6.28, 6.79) of women met symptom criteria. Based on the high specificity definition 2.70% (95% CI 2.53, 2.86) of women met the criteria. These percentages translated into 3.3 to 7.9 million United States women 18 years old or older with bladder pain syndrome/interstitial cystitis symptoms. Symptom severity and impact were comparable to those of adult women with established diagnoses. However, only 9.7% of the women reported being assigned a bladder pain syndrome/interstitial cystitis diagnosis.Bladder pain syndrome/interstitial cystitis symptoms are widespread among United States women and associated with considerable disability. These results suggest bladder pain syndrome/interstitial cystitis may be underdiagnosed.CONCLUSIONSBladder pain syndrome/interstitial cystitis symptoms are widespread among United States women and associated with considerable disability. These results suggest bladder pain syndrome/interstitial cystitis may be underdiagnosed. Purpose Bladder pain syndrome/interstitial cystitis is a poorly understood condition that can cause serious disability. We provide the first population based symptom prevalence estimate to our knowledge among United States adult females. Materials and Methods We developed and validated 2 case definitions to identify bladder pain syndrome/interstitial cystitis symptoms. Beginning in August 2007 we telephoned United States households, seeking adult women with bladder symptoms or a bladder pain syndrome/interstitial cystitis diagnosis. Second stage screening identified those subjects who met case definition criteria. Each completed a 60-minute interview on the severity and impact of bladder symptoms, health care seeking and demographics. Data collection ended in April 2009. Using population and nonresponse weights we calculated prevalence estimates based on definitions spanning a range of sensitivity and specificity. We used United States Census counts to estimate the number of affected women in 2006. The random sample included 146,231 households, of which 131,691 included an adult female. Of these households 32,474 reported an adult female with bladder symptoms or diagnosis, of which 12,752 completed the questionnaire. Results Based on the high sensitivity definition 6.53% (95% CI 6.28, 6.79) of women met symptom criteria. Based on the high specificity definition 2.70% (95% CI 2.53, 2.86) of women met the criteria. These percentages translated into 3.3 to 7.9 million United States women 18 years old or older with bladder pain syndrome/interstitial cystitis symptoms. Symptom severity and impact were comparable to those of adult women with established diagnoses. However, only 9.7% of the women reported being assigned a bladder pain syndrome/interstitial cystitis diagnosis. Conclusions Bladder pain syndrome/interstitial cystitis symptoms are widespread among United States women and associated with considerable disability. These results suggest bladder pain syndrome/interstitial cystitis may be underdiagnosed. |
| Author | Berry, Sandra H Elliott, Marc N Stoto, Michael A Clemens, J. Quentin Suttorp, Marika Nyberg, Leroy Bogart, Laura M Eggers, Paul |
| Author_xml | – sequence: 1 fullname: Berry, Sandra H – sequence: 2 fullname: Elliott, Marc N – sequence: 3 fullname: Suttorp, Marika – sequence: 4 fullname: Bogart, Laura M – sequence: 5 fullname: Stoto, Michael A – sequence: 6 fullname: Eggers, Paul – sequence: 7 fullname: Nyberg, Leroy – sequence: 8 fullname: Clemens, J. Quentin |
| BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=24340066$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/21683389$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9kk1r3DAQhkVJaT7aP9BD8aX0tBuNZMs2lMB2adpAoIFtzkKRx4m2srSV5IX995W7m37kkJMG9D7vSPPOKTly3iEhb4HOgYI4X8_XY_BzRgHmlM-BsxfkBCpWz3jdsiNyQiljs4qX9TE5jXFNKZRVzV6RYwai4bxpT4i7CbhVFp3GwvfFajdskh_iVH-yquswFDfKuHzhuuAHPL9yCUNMJhlli-XudxWLxeDdfbHoRpuKSxyyYSwylR6wuHUmYVeskkoYX5OXvbIR3xzOM3J7-fn78uvs-tuXq-XieqYrUaYZw5ox1guAStWtahG4xq7qocVGwJ3WFWtBNT0rRQ9QNiUA1F1Pe9YILpTiZ-Ri77sZ7wbsNLoUlJWbYAYVdtIrI_-_ceZB3vut5BVwzups8OFgEPzPEWOSg4karVUO_RhlUwtoGuCQle_-bfWnx-OMs-D9QaCiVrYPymkT_-pKXlIqRNY1e50OPsaAvdQmD8346YXGSqByil2u5RS7nGKXlMsce0bZE_TR_Vno4x7CHMTWYJBRm2kROhNQJ9l58zx-8QTX1jiTf_gDdxjXfgwuRyxBRiapXE3LOO0iAOVVWTH-C5o13Bc |
| CODEN | JOURAA |
| CitedBy_id | crossref_primary_10_1016_j_urology_2021_05_005 crossref_primary_10_1186_s12894_021_00934_0 crossref_primary_10_1038_s41585_021_00545_2 crossref_primary_10_1152_ajprenal_00290_2018 crossref_primary_10_1002_nau_22382 crossref_primary_10_2217_cpr_12_74 crossref_primary_10_1007_s40122_021_00244_1 crossref_primary_10_1016_j_juro_2014_03_093 crossref_primary_10_1016_S1701_2163_16_30049_4 crossref_primary_10_3390_diagnostics12010019 crossref_primary_10_1152_ajprenal_00408_2019 crossref_primary_10_1007_s00192_016_3059_8 crossref_primary_10_4103_UROS_UROS_26_22 crossref_primary_10_1002_nau_24205 crossref_primary_10_3389_fnsys_2018_00009 crossref_primary_10_1007_s11934_012_0264_y crossref_primary_10_1177_00099228241260119 crossref_primary_10_1186_s13287_017_0547_9 crossref_primary_10_1016_j_cont_2023_100596 crossref_primary_10_1177_23523735251322017 crossref_primary_10_17343_sdutfd_983094 crossref_primary_10_3389_fpain_2023_1149783 crossref_primary_10_1124_jpet_122_001480 crossref_primary_10_3389_fpain_2022_925834 crossref_primary_10_3892_wasj_2022_163 crossref_primary_10_1177_03915603231203431 crossref_primary_10_1007_s11255_019_02248_5 crossref_primary_10_1007_s00192_017_3307_6 crossref_primary_10_1097_j_pain_0000000000001505 crossref_primary_10_1681_ASN_2019040335 crossref_primary_10_3389_fphar_2022_780855 crossref_primary_10_1152_ajpregu_00239_2017 crossref_primary_10_1021_acs_molpharmaceut_8b00383 crossref_primary_10_5213_inj_1836182_091 crossref_primary_10_1016_j_pain_2014_05_029 crossref_primary_10_1016_S1634_7358_22_46550_8 crossref_primary_10_1097_SPV_0000000000000597 crossref_primary_10_1016_j_nwh_2016_01_006 crossref_primary_10_1038_nrurol_2016_227 crossref_primary_10_1007_s11136_011_0085_3 crossref_primary_10_1016_j_ogc_2021_05_010 crossref_primary_10_1016_j_urology_2018_02_039 crossref_primary_10_1111_bju_15519 crossref_primary_10_1371_journal_pone_0077854 crossref_primary_10_1371_journal_pone_0185686 crossref_primary_10_1080_14712598_2017_1375094 crossref_primary_10_1016_j_juro_2018_05_007 crossref_primary_10_1111_bju_13457 crossref_primary_10_1111_bju_14783 crossref_primary_10_1007_s11884_016_0387_y crossref_primary_10_1096_fj_202101025R crossref_primary_10_1002_nau_23493 crossref_primary_10_1159_000525849 crossref_primary_10_1016_j_urology_2015_12_040 crossref_primary_10_1016_j_urology_2018_05_004 crossref_primary_10_1007_s00192_014_2420_z crossref_primary_10_1038_srep39227 crossref_primary_10_1002_nau_25316 crossref_primary_10_1111_iju_13118 crossref_primary_10_1016_j_urology_2022_08_036 crossref_primary_10_1007_s11136_022_03183_2 crossref_primary_10_1177_17557380221111556 crossref_primary_10_1080_17512433_2018_1457435 crossref_primary_10_1007_s11136_012_0285_5 crossref_primary_10_3390_medicina58080981 crossref_primary_10_1371_journal_pone_0152055 crossref_primary_10_1371_journal_pone_0226390 crossref_primary_10_3389_fpain_2021_810809 crossref_primary_10_1007_s00404_017_4364_2 crossref_primary_10_18553_jmcp_2017_23_4_474 crossref_primary_10_1016_j_ejps_2019_105067 crossref_primary_10_1186_s12894_024_01407_w crossref_primary_10_1002_nau_23489 crossref_primary_10_1016_j_acuro_2021_11_006 crossref_primary_10_1177_1744806920970099 crossref_primary_10_33590_emjurol_20_00006 crossref_primary_10_1002_path_6040 crossref_primary_10_1097_SPV_0000000000000139 crossref_primary_10_1177_20514158231204591 crossref_primary_10_1016_j_cyto_2018_04_029 crossref_primary_10_1186_s13063_024_08450_w crossref_primary_10_1371_journal_pone_0072067 crossref_primary_10_1152_ajprenal_00075_2017 crossref_primary_10_5213_inj_2011_15_4_184 crossref_primary_10_1038_s41598_024_52625_z crossref_primary_10_1177_20552076231216280 crossref_primary_10_1371_journal_pone_0079617 crossref_primary_10_1128_iai_00360_23 crossref_primary_10_2217_pmt_14_21 crossref_primary_10_2147_OPTH_S285013 crossref_primary_10_1016_j_urology_2018_05_027 crossref_primary_10_3390_jcm10235669 crossref_primary_10_3390_toxins14120838 crossref_primary_10_1016_j_addr_2018_07_002 crossref_primary_10_5498_wjp_v14_i6_954 crossref_primary_10_1016_j_juro_2014_08_042 crossref_primary_10_1016_j_jpsychores_2014_09_010 crossref_primary_10_1097_MPG_0000000000000599 crossref_primary_10_1002_nau_23555 crossref_primary_10_1111_head_14099 crossref_primary_10_1371_journal_pone_0225455 crossref_primary_10_1007_s00702_025_02906_2 crossref_primary_10_1007_s11884_021_00629_0 crossref_primary_10_1080_09286586_2022_2031227 crossref_primary_10_1016_j_brainres_2015_01_008 crossref_primary_10_1371_journal_pone_0317790 crossref_primary_10_1038_nrurol_2014_244 crossref_primary_10_1055_a_2068_2687 crossref_primary_10_1097_SPV_0000000000001195 crossref_primary_10_7759_cureus_14549 crossref_primary_10_1002_nau_25283 crossref_primary_10_1177_17562872221109023 crossref_primary_10_1016_j_addr_2012_02_003 crossref_primary_10_4111_icu_2019_60_5_359 crossref_primary_10_1007_s00192_019_04075_9 crossref_primary_10_1007_s00345_019_03045_6 crossref_primary_10_1111_bju_12675 crossref_primary_10_1111_j_1464_410X_2011_10860_x crossref_primary_10_1038_s41583_021_00536_7 crossref_primary_10_1111_luts_12214 crossref_primary_10_1016_j_brainres_2016_02_039 crossref_primary_10_1016_j_bbadis_2024_167305 crossref_primary_10_1002_nau_23421 crossref_primary_10_1038_s41598_017_16129_3 crossref_primary_10_1007_s00120_013_3130_8 crossref_primary_10_1152_physrev_00041_2019 crossref_primary_10_1177_2051415819893562 crossref_primary_10_1007_s00482_014_1409_3 crossref_primary_10_1097_MD_0000000000021422 crossref_primary_10_1007_s11934_022_01132_7 crossref_primary_10_1007_s11884_014_0287_y crossref_primary_10_1016_j_jpsychores_2014_10_003 crossref_primary_10_1016_j_juro_2017_02_021 crossref_primary_10_2147_IJGM_S351287 crossref_primary_10_1371_journal_pone_0239282 crossref_primary_10_1038_nrurol_2012_178 crossref_primary_10_1016_j_neuroscience_2017_01_021 crossref_primary_10_1007_s00192_015_2780_z crossref_primary_10_1016_j_jpain_2015_03_014 crossref_primary_10_1097_j_pain_0000000000002944 crossref_primary_10_1097_SPV_0000000000001536 crossref_primary_10_1016_j_neuropharm_2022_109369 crossref_primary_10_3389_fimmu_2022_960667 crossref_primary_10_1097_GCO_0000000000000747 crossref_primary_10_1002_nau_23459 crossref_primary_10_1007_s11884_023_00716_4 crossref_primary_10_1146_annurev_physiol_020518_114525 crossref_primary_10_1097_j_pain_0000000000000886 crossref_primary_10_1038_srep26083 crossref_primary_10_1038_s41585_023_00850_y crossref_primary_10_3389_fnsys_2022_882493 crossref_primary_10_1089_jwh_2017_6566 crossref_primary_10_1371_journal_pone_0137310 crossref_primary_10_1007_s00192_019_04036_2 crossref_primary_10_1016_j_inat_2022_101517 crossref_primary_10_12659_MSM_897350 crossref_primary_10_1016_j_juro_2014_10_086 crossref_primary_10_1016_j_physbeh_2023_114358 crossref_primary_10_1097_AOG_0000000000001892 crossref_primary_10_1097_j_pain_0000000000002813 crossref_primary_10_1002_anbr_202100138 crossref_primary_10_1017_S0033291723001885 crossref_primary_10_1097_SPV_0000000000001307 crossref_primary_10_1002_nau_22475 crossref_primary_10_1007_s41974_020_00127_x crossref_primary_10_1016_j_juro_2015_01_086 crossref_primary_10_1152_ajprenal_00202_2014 crossref_primary_10_1002_nau_24771 crossref_primary_10_1007_s11255_014_0828_5 crossref_primary_10_1371_journal_pone_0127628 crossref_primary_10_1016_j_urology_2021_09_018 crossref_primary_10_1097_ICB_0000000000001440 crossref_primary_10_1016_j_bj_2021_06_006 crossref_primary_10_1177_20514158221122521 crossref_primary_10_1038_s41598_017_11062_x crossref_primary_10_1007_s11884_016_0368_1 crossref_primary_10_1002_nau_24413 crossref_primary_10_3390_jcm11216345 crossref_primary_10_1016_j_ajur_2014_09_004 crossref_primary_10_1124_jpet_118_248567 crossref_primary_10_1016_j_juro_2013_10_102 crossref_primary_10_1016_j_nicl_2017_11_014 crossref_primary_10_1016_j_urology_2023_08_025 crossref_primary_10_2139_ssrn_4012384 crossref_primary_10_3390_toxins12020075 crossref_primary_10_1177_02683555221112567 crossref_primary_10_1007_s00192_019_03970_5 crossref_primary_10_1002_nau_24840 crossref_primary_10_1007_s40122_023_00559_1 crossref_primary_10_1002_nau_22542 crossref_primary_10_1177_0193945921990730 crossref_primary_10_1002_nau_25376 crossref_primary_10_1002_ggn2_202200013 crossref_primary_10_1016_j_juro_2017_09_167 crossref_primary_10_1111_luts_12365 crossref_primary_10_1111_jcmm_17132 crossref_primary_10_1016_j_urology_2021_07_019 crossref_primary_10_62347_BLED2401 crossref_primary_10_1111_1552_6909_12287 crossref_primary_10_1016_j_juro_2012_08_088 crossref_primary_10_1097_SPV_0000000000000985 crossref_primary_10_1186_s13063_022_06554_9 crossref_primary_10_5213_inj_2040104_052 crossref_primary_10_1016_j_urology_2016_08_038 crossref_primary_10_1177_2053369120936426 crossref_primary_10_1111_iju_13778 crossref_primary_10_1097_SPV_0000000000001166 crossref_primary_10_1148_radiol_12111869 crossref_primary_10_3390_jcm9061935 crossref_primary_10_3727_096368915X689523 crossref_primary_10_1002_nau_24270 crossref_primary_10_1016_j_ejogrb_2021_08_025 crossref_primary_10_1002_prp2_697 crossref_primary_10_3389_fphys_2023_1232017 crossref_primary_10_1007_s11884_024_00771_5 crossref_primary_10_1038_s41598_021_96810_w crossref_primary_10_1016_j_juro_2011_10_040 crossref_primary_10_1097_IAE_0000000000003078 crossref_primary_10_1002_nau_23861 crossref_primary_10_1007_s11908_014_0454_5 crossref_primary_10_1101_cshperspect_a039172 crossref_primary_10_1038_srep19670 crossref_primary_10_1007_s00345_023_04588_5 crossref_primary_10_1002_nau_24958 crossref_primary_10_1186_1471_2490_14_58 crossref_primary_10_1007_s11255_024_04251_x crossref_primary_10_1186_1471_2490_14_57 crossref_primary_10_1038_s41598_018_29085_3 crossref_primary_10_1007_s00120_017_0408_2 crossref_primary_10_1016_j_bcp_2022_115047 crossref_primary_10_1111_1471_0528_14433 crossref_primary_10_1007_s00192_021_04812_z crossref_primary_10_1016_j_urology_2020_06_032 crossref_primary_10_1097_j_pain_0000000000002909 crossref_primary_10_1007_s11255_021_03084_2 crossref_primary_10_1038_s41598_019_41971_y crossref_primary_10_1016_j_cont_2023_101056 crossref_primary_10_1097_JWH_0000000000000062 crossref_primary_10_1002_nau_24983 crossref_primary_10_1016_j_cont_2023_101051 crossref_primary_10_1097_AOG_0000000000002951 crossref_primary_10_1038_s41585_018_0135_5 crossref_primary_10_1007_s11884_013_0214_7 crossref_primary_10_1002_nau_22202 crossref_primary_10_1002_nau_24864 crossref_primary_10_1007_s11884_019_00571_2 crossref_primary_10_1152_ajprenal_00125_2024 crossref_primary_10_1517_14728214_2015_1105216 crossref_primary_10_1016_j_msec_2020_111773 crossref_primary_10_3390_ijms24055055 crossref_primary_10_1242_dev_198184 crossref_primary_10_1016_j_juro_2012_08_189 crossref_primary_10_2147_RRU_S238746 crossref_primary_10_1007_s11884_014_0273_4 crossref_primary_10_1016_j_ebiom_2016_03_040 crossref_primary_10_1007_s00192_019_04038_0 crossref_primary_10_1152_ajpregu_00585_2012 crossref_primary_10_1007_s00192_015_2815_5 crossref_primary_10_1371_journal_pone_0235384 crossref_primary_10_1371_journal_pone_0309815 crossref_primary_10_1002_nau_25027 crossref_primary_10_1007_s00192_020_04647_0 crossref_primary_10_4111_icu_2020_61_1_75 crossref_primary_10_1002_tre_885 crossref_primary_10_1097_j_pain_0000000000001368 crossref_primary_10_1097_j_pain_0000000000003424 crossref_primary_10_1371_journal_pone_0298981 crossref_primary_10_1523_JNEUROSCI_1473_12_2012 crossref_primary_10_1530_JOE_13_0422 crossref_primary_10_1016_S1636_5410_22_46457_9 crossref_primary_10_1007_s40266_020_00810_w crossref_primary_10_1177_1756287218818030 crossref_primary_10_1007_s11255_023_03770_3 crossref_primary_10_2196_21909 crossref_primary_10_1007_s11884_011_0119_2 crossref_primary_10_1248_bpb_b20_00742 crossref_primary_10_1007_s11255_022_03108_5 crossref_primary_10_1016_j_acuroe_2022_02_007 crossref_primary_10_1016_j_jmig_2014_02_008 crossref_primary_10_14309_ajg_0000000000002137 crossref_primary_10_5812_aapm_101848 crossref_primary_10_1016_j_juro_2015_05_105 crossref_primary_10_3390_jcm13020315 crossref_primary_10_1080_14740338_2021_1921733 crossref_primary_10_1152_ajprenal_00234_2016 crossref_primary_10_1016_j_urology_2011_12_053 crossref_primary_10_1002_nau_24802 crossref_primary_10_1002_nau_24923 crossref_primary_10_1038_s41598_018_29592_3 crossref_primary_10_1007_s00192_015_2652_6 crossref_primary_10_1002_nau_25579 crossref_primary_10_1007_s00120_020_01309_3 crossref_primary_10_1371_journal_pone_0198816 crossref_primary_10_30841_2307_5090_4_2019_195158 crossref_primary_10_1097_GME_0000000000001956 crossref_primary_10_1016_j_pain_2014_09_002 crossref_primary_10_12688_f1000research_18799_1 crossref_primary_10_1007_s12031_013_0033_5 crossref_primary_10_1080_01621459_2022_2066536 crossref_primary_10_1016_j_pmn_2015_06_001 crossref_primary_10_1002_nau_23024 crossref_primary_10_3389_fimmu_2016_00140 crossref_primary_10_1007_s11262_020_01767_z crossref_primary_10_1016_j_urology_2018_07_046 crossref_primary_10_3389_fpain_2021_757878 crossref_primary_10_33590_emj_20_00029 crossref_primary_10_1111_luts_12058 crossref_primary_10_3390_diagnostics14232734 crossref_primary_10_4111_icu_2020_61_S1_S8 crossref_primary_10_1016_j_urology_2024_03_043 crossref_primary_10_1016_j_anndiagpath_2013_03_004 crossref_primary_10_3390_biomedicines9080865 crossref_primary_10_3390_diagnostics12051037 crossref_primary_10_1177_1756287219868590 crossref_primary_10_3389_fimmu_2024_1413078 crossref_primary_10_1016_j_pmn_2017_11_001 crossref_primary_10_1016_j_urology_2012_06_059 crossref_primary_10_1097_01720610_201206000_00006 crossref_primary_10_1097_SPV_0000000000001361 crossref_primary_10_1080_15384101_2017_1295184 crossref_primary_10_1097_SPV_0000000000001374 crossref_primary_10_1155_2022_7149467 crossref_primary_10_1155_2014_120525 crossref_primary_10_1111_iju_12476 crossref_primary_10_1016_j_jddst_2024_106110 crossref_primary_10_18632_aging_205170 crossref_primary_10_5301_uj_5000262 crossref_primary_10_1002_ejp_1942 crossref_primary_10_23736_S0393_3660_24_05575_X crossref_primary_10_1097_SPV_0b013e3182686631 crossref_primary_10_1016_j_cyto_2018_05_012 crossref_primary_10_1371_journal_pone_0122597 crossref_primary_10_1111_luts_12395 crossref_primary_10_1177_02683555231219737 crossref_primary_10_3390_toxins10070260 crossref_primary_10_1016_j_juro_2016_03_003 crossref_primary_10_1002_nau_24702 crossref_primary_10_3390_ph10020037 crossref_primary_10_56984_8ZG140EA9 crossref_primary_10_1097_SPV_0000000000000840 crossref_primary_10_1177_17562872211022478 crossref_primary_10_1186_1744_8069_8_20 crossref_primary_10_4103_UROS_UROS_155_20 crossref_primary_10_1093_abm_kax060 crossref_primary_10_1038_tp_2016_168 crossref_primary_10_1016_j_jpain_2022_08_005 crossref_primary_10_1016_j_juro_2014_10_120 crossref_primary_10_1097_j_pain_0000000000000238 crossref_primary_10_1126_scitranslmed_3003804 crossref_primary_10_1016_j_neuropharm_2021_108701 crossref_primary_10_1517_13543784_2016_1162290 crossref_primary_10_3389_fpain_2021_748385 crossref_primary_10_3390_mps5030040 crossref_primary_10_1016_j_urology_2017_05_016 crossref_primary_10_1002_nau_23284 crossref_primary_10_24884_1682_6655_2017_16_2_25_31 crossref_primary_10_3346_jkms_2021_36_e293 crossref_primary_10_1080_15360288_2022_2089437 crossref_primary_10_1080_24740527_2020_1785854 crossref_primary_10_3389_fimmu_2024_1395580 crossref_primary_10_1038_s41598_023_38584_x crossref_primary_10_1097_j_pain_0000000000002895 crossref_primary_10_1002_nau_24019 crossref_primary_10_1016_j_neuroscience_2014_08_064 crossref_primary_10_1007_s00192_020_04593_x crossref_primary_10_1016_j_juro_2011_09_051 crossref_primary_10_1016_j_juro_2013_07_018 crossref_primary_10_1097_SPV_0000000000000854 crossref_primary_10_1016_j_ajur_2015_04_008 crossref_primary_10_3390_jcm9030766 crossref_primary_10_1038_s41598_018_22771_2 crossref_primary_10_3389_fimmu_2022_1057746 crossref_primary_10_2147_JPR_S396009 crossref_primary_10_1097_j_pain_0000000000003188 crossref_primary_10_1016_j_urology_2022_10_017 |
| Cites_doi | 10.1016/S0022-5347(05)67637-9 10.1016/S0090-4295(99)80333-1 10.1016/j.urology.2008.01.053 10.1016/j.juro.2009.12.103 10.1016/j.juro.2006.09.032 10.1001/archinte.167.18.1922 10.1016/S0022-5347(05)64847-1 10.1093/poq/nfn011 10.1097/01.ju.0000146114.53828.82 10.1097/01.ju.0000165170.43617.be 10.1016/S0022-5347(01)61947-5 10.1093/poq/nfl033 10.1016/j.juro.2006.11.084 |
| ContentType | Journal Article |
| Copyright | American Urological Association Education and Research, Inc. 2011 American Urological Association Education and Research, Inc. 2015 INIST-CNRS Copyright © 2011 American Urological Association Education and Research, Inc. Published by Elsevier Inc. All rights reserved. 2011 by American Urological Association Education and Research, Inc. 2011 |
| Copyright_xml | – notice: American Urological Association Education and Research, Inc. – notice: 2011 American Urological Association Education and Research, Inc. – notice: 2015 INIST-CNRS – notice: Copyright © 2011 American Urological Association Education and Research, Inc. Published by Elsevier Inc. All rights reserved. – notice: 2011 by American Urological Association Education and Research, Inc. 2011 |
| DBID | AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 7X8 5PM |
| DOI | 10.1016/j.juro.2011.03.132 |
| DatabaseName | CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic PubMed Central (Full Participant titles) |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1527-3792 |
| EndPage | 544 |
| ExternalDocumentID | PMC3513327 21683389 24340066 10_1016_j_juro_2011_03_132 S0022534711035452 1_s2_0_S0022534711035452 |
| Genre | Journal Article Research Support, N.I.H., Extramural |
| GeographicLocations | United States North America America |
| GeographicLocations_xml | – name: United States |
| GrantInformation_xml | – fundername: NIDDK NIH HHS grantid: U01 DK070234 – fundername: NIDDK NIH HHS grantid: U01DK070234-01 – fundername: National Institute of Diabetes and Digestive and Kidney Diseases : NIDDK grantid: U01 DK070234 || DK |
| GroupedDBID | --- --K .55 .GJ .XZ 08P 0R~ 123 1B1 1CY 354 3O- 4.4 457 4G. 4Q1 4Q2 4Q3 53G 5RE 5VS 7-5 AAAAV AAEDT AAEDW AAGIX AAHPQ AAIQE AAJCS AAKAS AALRI AAMOA AAQFI AAQKA AAQQT AAQXK AASCR AASXQ AAXUO ABASU ABCQX ABDIG ABJNI ABLJU ABMAC ABOCM ABPPZ ABVCZ ABWVN ACGFS ACIJW ACILI ACLDA ACOAL ACRPL ACXJB ADGGA ADHPY ADMUD ADNKB ADNMO ADPAM ADZCM AEBDS AEETU AENEX AFDTB AFEXH AFFNX AFTRI AFUWQ AGHFR AHOMT AHQNM AHRYX AHVBC AI. AINUH AITUG AIZYK AJCLO AJIOK AJNWD AJZMW AKCTQ AKULP ALKUP ALMA_UNASSIGNED_HOLDINGS ALMTX AMJPA AMKUR AMNEI AMRAJ ASGHL ASPBG AVWKF AZFZN BCGUY BELOY BYPQX C45 C5W CS3 DIWNM DU5 EBS EEVPB EJD ERAAH EX3 F5P FCALG FDB FEDTE FGOYB GBLVA GNXGY GQDEL HLJTE HVGLF HZ~ H~9 IH2 IHE IKREB IKYAY IPNFZ J5H KMI L7B M41 MJL MO0 N4W NQ- NTWIH O9- OAG OAH OB3 OBH ODMTH OGROG OHH OL1 OVD OWU OWV OWW OWY OWZ P2P PKN QTD R2- RIG RLZ ROL RPZ SEL SES SJN SSZ TEORI TSPGW UDS UNMZH UV1 VH1 VVN WOW X7M XH2 XYM YFH YOC ZCG ZFV ZGI ZXP ZY1 ZZMQN AGZHU AHPSJ ALXNB ZA5 AAYXX ABPXF ABXYN ABZZY ACVFH ACZKN ADCNI ADGHP AFBFQ AFNMH AGQPQ AHQVU AIGII AOQMC CITATION IQODW CGR CUY CVF ECM EIF NPM 7X8 5PM |
| ID | FETCH-LOGICAL-c564t-2e7222f6115a79a9e13ced5f19e861bcc5291a8f246f114841117df0f28636aa3 |
| ISSN | 0022-5347 1527-3792 |
| IngestDate | Thu Aug 21 17:30:14 EDT 2025 Fri Jul 11 01:54:11 EDT 2025 Thu Apr 03 06:52:51 EDT 2025 Mon Jul 21 09:13:25 EDT 2025 Thu Apr 24 23:00:07 EDT 2025 Tue Jul 01 02:19:26 EDT 2025 Fri Feb 23 02:27:19 EST 2024 Sun Feb 23 10:19:34 EST 2025 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 2 |
| Keywords | ORC Interstitial Cystitis Problem Index urinary bladder interstitial bladder pain syndrome/interstitial cystitis BPS/IC cross-sectional studies SF-36 prevalence ICPI ICSI Interstitial Cystitis Symptom Index RAND Interstitial Cystitis Epidemiology Medical Outcomes Study Short Form-36 Opinion Research Corporation cystitis RICE Human Nephrology Urinary system disease Prevalence Urinary tract disease Epidemiology Syndrome Urology Symptomatology Pain Urinary system Urinary bladder Cross sectional study Adult Female Interstitial Interstitial cystitis |
| Language | English |
| License | https://www.elsevier.com/tdm/userlicense/1.0 CC BY 4.0 Copyright © 2011 American Urological Association Education and Research, Inc. Published by Elsevier Inc. All rights reserved. |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-c564t-2e7222f6115a79a9e13ced5f19e861bcc5291a8f246f114841117df0f28636aa3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Financial interest and/or other relationship with Merck, Medtronic, Lilly, Pfizer and Afferent Pharmaceuticals Inc. |
| OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/3513327 |
| PMID | 21683389 |
| PQID | 876188131 |
| PQPubID | 23479 |
| PageCount | 5 |
| ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_3513327 proquest_miscellaneous_876188131 pubmed_primary_21683389 pascalfrancis_primary_24340066 crossref_citationtrail_10_1016_j_juro_2011_03_132 crossref_primary_10_1016_j_juro_2011_03_132 elsevier_sciencedirect_doi_10_1016_j_juro_2011_03_132 elsevier_clinicalkeyesjournals_1_s2_0_S0022534711035452 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2011-08-01 |
| PublicationDateYYYYMMDD | 2011-08-01 |
| PublicationDate_xml | – month: 08 year: 2011 text: 2011-08-01 day: 01 |
| PublicationDecade | 2010 |
| PublicationPlace | New York, NY |
| PublicationPlace_xml | – name: New York, NY – name: United States |
| PublicationTitle | The Journal of urology |
| PublicationTitleAlternate | J Urol |
| PublicationYear | 2011 |
| Publisher | Elsevier Inc Elsevier |
| Publisher_xml | – name: Elsevier Inc – name: Elsevier |
| References | O'Leary, Sant, Fowler (bib11) 1997; 49 Groves, Peytcheva (bib14) 2008; 72 Bogart, Berry, Clemens (bib1) 2007; 177 Lifford, Curhan (bib6) 2009; 73 Curhan, Speizer, Hunter (bib8) 1999; 161 Groves (bib13) 2006; 70 Leppilahti, Tammela, Huhtala (bib4) 2002; 168 Berry, Bogart, Pham (bib9) 2010; 183 Ware, Kosinski, Gandek (bib10) 2005 Dimitrakov, Kroenke, Steers (bib3) 2007; 167 Clemens, Meenan, O'Keeffe Rosetti (bib5) 2005; 174 Clemens, Link, Eggers (bib7) 2007; 177 Clemens, Meenan, Rosetti (bib12) 2005; 173 Propert, Schaeffer, Brensinger (bib2) 2000; 163 O'Leary (10.1016/j.juro.2011.03.132_bib11) 1997; 49 Berry (10.1016/j.juro.2011.03.132_bib9) 2010; 183 Lifford (10.1016/j.juro.2011.03.132_bib6) 2009; 73 Clemens (10.1016/j.juro.2011.03.132_bib12) 2005; 173 Groves (10.1016/j.juro.2011.03.132_bib13) 2006; 70 Clemens (10.1016/j.juro.2011.03.132_bib5) 2005; 174 Propert (10.1016/j.juro.2011.03.132_bib2) 2000; 163 Leppilahti (10.1016/j.juro.2011.03.132_bib4) 2002; 168 Dimitrakov (10.1016/j.juro.2011.03.132_bib3) 2007; 167 Clemens (10.1016/j.juro.2011.03.132_bib7) 2007; 177 Groves (10.1016/j.juro.2011.03.132_bib14) 2008; 72 Curhan (10.1016/j.juro.2011.03.132_bib8) 1999; 161 Bogart (10.1016/j.juro.2011.03.132_bib1) 2007; 177 Ware (10.1016/j.juro.2011.03.132_bib10) 2005 12050508 - J Urol. 2002 Jul;168(1):139-43 9915446 - J Urol. 1999 Feb;161(2):549-52 20303099 - J Urol. 2010 May;183(5):1848-52 19118882 - Urology. 2009 Mar;73(3):494-8 17382739 - J Urol. 2007 Apr;177(4):1390-4 9146003 - Urology. 1997 May;49(5A Suppl):58-63 17222607 - J Urol. 2007 Feb;177(2):450-6 16006901 - J Urol. 2005 Aug;174(2):576-80 10751852 - J Urol. 2000 May;163(5):1434-9 17923590 - Arch Intern Med. 2007 Oct 8;167(18):1922-9 15592041 - J Urol. 2005 Jan;173(1):98-102; discussion 102 |
| References_xml | – volume: 72 start-page: 167 year: 2008 ident: bib14 article-title: The impact of nonresponse rates on nonresponse bias: a meta-analysis publication-title: Public Opin Q – volume: 168 start-page: 139 year: 2002 ident: bib4 article-title: Prevalence of symptoms related to interstitial cystitis in women: a population based study in Finland publication-title: J Urol – volume: 49 start-page: 58 year: 1997 ident: bib11 article-title: The interstitial cystitis symptom index and problem index publication-title: Urology – volume: 70 start-page: 646 year: 2006 ident: bib13 article-title: Nonresponse rates and nonresponse bias in household surveys publication-title: Public Opin Q – volume: 161 start-page: 549 year: 1999 ident: bib8 article-title: Epidemiology of interstitial cystitis: a population based study publication-title: J Urol – volume: 73 start-page: 494 year: 2009 ident: bib6 article-title: Prevalence of painful bladder syndrome in older women publication-title: Urology – volume: 183 start-page: 1848 year: 2010 ident: bib9 article-title: Development, validation and testing of an epidemiological case definition of interstitial cystitis/painful bladder syndrome publication-title: J Urol – volume: 163 start-page: 1434 year: 2000 ident: bib2 article-title: A prospective study of interstitial cystitis: results of longitudinal followup of the interstitial cystitis data base cohort publication-title: J Urol – year: 2005 ident: bib10 article-title: SF-36 Health Survey: Manual & Interpretation Guide – volume: 174 start-page: 576 year: 2005 ident: bib5 article-title: Prevalence of interstitial cystitis symptoms in a managed care population publication-title: J Urol – volume: 167 start-page: 1922 year: 2007 ident: bib3 article-title: Pharmacologic management of painful bladder syndrome/interstitial cystitis: a systematic review publication-title: Arch Intern Med – volume: 177 start-page: 1390 year: 2007 ident: bib7 article-title: Prevalence of painful bladder symptoms and effect on quality of life in black, Hispanic and white men and women publication-title: J Urol – volume: 177 start-page: 450 year: 2007 ident: bib1 article-title: Symptoms of interstitial cystitis, painful bladder syndrome and similar diseases in women: a systematic review publication-title: J Urol – volume: 173 start-page: 98 year: 2005 ident: bib12 article-title: Prevalence and incidence of interstitial cystitis in a managed care population publication-title: J Urol – volume: 163 start-page: 1434 year: 2000 ident: 10.1016/j.juro.2011.03.132_bib2 article-title: A prospective study of interstitial cystitis: results of longitudinal followup of the interstitial cystitis data base cohort publication-title: J Urol doi: 10.1016/S0022-5347(05)67637-9 – volume: 49 start-page: 58 year: 1997 ident: 10.1016/j.juro.2011.03.132_bib11 article-title: The interstitial cystitis symptom index and problem index publication-title: Urology doi: 10.1016/S0090-4295(99)80333-1 – volume: 73 start-page: 494 year: 2009 ident: 10.1016/j.juro.2011.03.132_bib6 article-title: Prevalence of painful bladder syndrome in older women publication-title: Urology doi: 10.1016/j.urology.2008.01.053 – volume: 183 start-page: 1848 year: 2010 ident: 10.1016/j.juro.2011.03.132_bib9 article-title: Development, validation and testing of an epidemiological case definition of interstitial cystitis/painful bladder syndrome publication-title: J Urol doi: 10.1016/j.juro.2009.12.103 – volume: 177 start-page: 450 year: 2007 ident: 10.1016/j.juro.2011.03.132_bib1 article-title: Symptoms of interstitial cystitis, painful bladder syndrome and similar diseases in women: a systematic review publication-title: J Urol doi: 10.1016/j.juro.2006.09.032 – volume: 167 start-page: 1922 year: 2007 ident: 10.1016/j.juro.2011.03.132_bib3 article-title: Pharmacologic management of painful bladder syndrome/interstitial cystitis: a systematic review publication-title: Arch Intern Med doi: 10.1001/archinte.167.18.1922 – volume: 168 start-page: 139 year: 2002 ident: 10.1016/j.juro.2011.03.132_bib4 article-title: Prevalence of symptoms related to interstitial cystitis in women: a population based study in Finland publication-title: J Urol doi: 10.1016/S0022-5347(05)64847-1 – volume: 72 start-page: 167 year: 2008 ident: 10.1016/j.juro.2011.03.132_bib14 article-title: The impact of nonresponse rates on nonresponse bias: a meta-analysis publication-title: Public Opin Q doi: 10.1093/poq/nfn011 – volume: 173 start-page: 98 year: 2005 ident: 10.1016/j.juro.2011.03.132_bib12 article-title: Prevalence and incidence of interstitial cystitis in a managed care population publication-title: J Urol doi: 10.1097/01.ju.0000146114.53828.82 – volume: 174 start-page: 576 year: 2005 ident: 10.1016/j.juro.2011.03.132_bib5 article-title: Prevalence of interstitial cystitis symptoms in a managed care population publication-title: J Urol doi: 10.1097/01.ju.0000165170.43617.be – year: 2005 ident: 10.1016/j.juro.2011.03.132_bib10 – volume: 161 start-page: 549 year: 1999 ident: 10.1016/j.juro.2011.03.132_bib8 article-title: Epidemiology of interstitial cystitis: a population based study publication-title: J Urol doi: 10.1016/S0022-5347(01)61947-5 – volume: 70 start-page: 646 year: 2006 ident: 10.1016/j.juro.2011.03.132_bib13 article-title: Nonresponse rates and nonresponse bias in household surveys publication-title: Public Opin Q doi: 10.1093/poq/nfl033 – volume: 177 start-page: 1390 year: 2007 ident: 10.1016/j.juro.2011.03.132_bib7 article-title: Prevalence of painful bladder symptoms and effect on quality of life in black, Hispanic and white men and women publication-title: J Urol doi: 10.1016/j.juro.2006.11.084 – reference: 9915446 - J Urol. 1999 Feb;161(2):549-52 – reference: 15592041 - J Urol. 2005 Jan;173(1):98-102; discussion 102 – reference: 17222607 - J Urol. 2007 Feb;177(2):450-6 – reference: 17382739 - J Urol. 2007 Apr;177(4):1390-4 – reference: 16006901 - J Urol. 2005 Aug;174(2):576-80 – reference: 20303099 - J Urol. 2010 May;183(5):1848-52 – reference: 9146003 - Urology. 1997 May;49(5A Suppl):58-63 – reference: 10751852 - J Urol. 2000 May;163(5):1434-9 – reference: 19118882 - Urology. 2009 Mar;73(3):494-8 – reference: 12050508 - J Urol. 2002 Jul;168(1):139-43 – reference: 17923590 - Arch Intern Med. 2007 Oct 8;167(18):1922-9 |
| SSID | ssj0014572 |
| Score | 2.5429323 |
| Snippet | Purpose Bladder pain syndrome/interstitial cystitis is a poorly understood condition that can cause serious disability. We provide the first population based... Bladder pain syndrome/interstitial cystitis is a poorly understood condition that can cause serious disability. We provide the first population based symptom... |
| SourceID | pubmedcentral proquest pubmed pascalfrancis crossref elsevier |
| SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 540 |
| SubjectTerms | Adolescent Adult Aged Biological and medical sciences cross-sectional studies cystitis Cystitis, Interstitial - diagnosis Cystitis, Interstitial - epidemiology Female Humans interstitial Medical sciences Middle Aged Nephrology. Urinary tract diseases Prevalence United States - epidemiology urinary bladder Urinary system involvement in other diseases. Miscellaneous Urinary tract. Prostate gland Urology Young Adult |
| Title | Prevalence of Symptoms of Bladder Pain Syndrome/Interstitial Cystitis Among Adult Females in the United States |
| URI | https://www.clinicalkey.es/playcontent/1-s2.0-S0022534711035452 https://dx.doi.org/10.1016/j.juro.2011.03.132 https://www.ncbi.nlm.nih.gov/pubmed/21683389 https://www.proquest.com/docview/876188131 https://pubmed.ncbi.nlm.nih.gov/PMC3513327 |
| Volume | 186 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lj9MwELZKV0JICPGmPFY-cKtaajt2kmNbsVSIrpB2F-3NclJnadk2VZMelp_DL2UcO4-WsoK9RFESx0nm83hmMvMZofcqYor5YdQLaQAOykzHvTAgoqcCkehwECuhTEB_eiomF97nS37Zav1qZC1t86gf_zxYV3IXqcIxkKupkv0PyVY3hQOwD_KFLUgYtv8kY8O_pIqqoaL25Ga5ztNlkZsxujYaZQMG4hzGr2MlgI6KAKBJDzCB8vFNsZd1h8WKQ0NDxdE90Uu4ZVbmP-7YpE1Ltq4pK6zZ7WYnPj_SG_t__kxB36o76R9KEjE8AafVmbNtnqebtTsz_1GHCtIrZSuLTBW36k77zViFDb66WEVdO8CZ5djsa6dyqVFz4Z5OFg3w0YaG5ZbdyU3W3JJH_jEP2JDEor-At3c8raxPbCS1AYz1skAGJSIAVz2s58QqU_HrdMzMEjjUv4eOKLgitI2OPo2-fBtW_6o87lec9ObdXGmWzSLcf4CCfNr29jdL6OFaZTA-E7uwyiHPZz-Bt2ERnT9Gj5zw8dDi8glq6dVTdH_qkjWeoVUNT5wmuISn2XfwxAaeuITnhyY4cQlOXIATF-DEDpwYWgE4sQUntuB8ji5OPp6PJz23vEcv5sLLe1TD16SJAJ9E-aEKNWGxnvGEhDoQJIpjTkOigoR6IjFeuwfTsj9LBgkNBBNKsReovUpX-hXCIohDzcHajjj1Ip4onjDPowNN4sSnXHcQKT-1jB33vVmC5VqWSY4LaSQljaTkgEmQVAd1qzZry_xy69V-KUFZ1jTDLKwzpy4ySWRG5UCa7AhqYAJ2NwP3BVryqqWzeq01KwHMt_Z4vAOU6iGpxzzjSXQQLpEjYc4wPwLVSqfbTIIFRIKAMNJBLy2Q6sYOnPA-OxCrLjB09LtnVvPvBS29Gyev79zyDXpQK423qJ1vtvodmPx5dOzG3G-IxQME |
| linkProvider | Elsevier |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Prevalence+of+Symptoms+of+Bladder+Pain+Syndrome%2FInterstitial+Cystitis+Among+Adult+Females+in+the+United+States&rft.jtitle=The+Journal+of+urology&rft.au=Berry%2C+Sandra+H.&rft.au=Elliott%2C+Marc+N.&rft.au=Suttorp%2C+Marika&rft.au=Bogart%2C+Laura+M.&rft.date=2011-08-01&rft.issn=0022-5347&rft.eissn=1527-3792&rft.volume=186&rft.issue=2&rft.spage=540&rft.epage=544&rft_id=info:doi/10.1016%2Fj.juro.2011.03.132&rft_id=info%3Apmid%2F21683389&rft.externalDocID=PMC3513327 |
| thumbnail_m | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F00225347%2FS0022534711X00095%2Fcov150h.gif |